Paper8095909
Cleavage of human MDR1 mRNA by a hammerhead ribozyme.
Kobayashi H and 3 others. FEBS Lett, 1993. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Cleavage of human MDR1 mRNA by a hammerhead ribozyme. Papers, record 8095909. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8095909
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance | Major topic |
| Membrane Glycoproteins | Major topic |
| RNA, Catalytic | Major topic |
| RNA, Messenger | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Base Sequence | |
| Binding Sites | |
| Codon | |
| Humans | |
| Molecular Sequence Data | |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | |
| Trimetrexate | |
| Tumor Cells, Cultured | |
| Vincristine |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30071629 | Analysis of Candidate Idarubicin Drug Resistance Genes in MOLT-3 Cells Using Exome Nuclear DNA. | Genes (Basel) | 2018 | https://conductscience.org/library/papers/30071629 | PubMed |
| 19079736 | Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. | Curr Mol Pharmacol | 2008 | https://conductscience.org/library/papers/19079736 | PubMed |
| 19002787 | Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance. | Cytotechnology | 1998 | https://conductscience.org/library/papers/19002787 | PubMed |
| 15316104 | Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/15316104 | PubMed |
| 8626292 | RNases involved in ribozyme degradation in Escherichia coli. | J Bacteriol | 1996 | https://conductscience.org/library/papers/8626292 | PubMed |
| 7948302 | P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells. | Ann Hematol | 1994 | https://conductscience.org/library/papers/7948302 | PubMed |
| 7925305 | Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. | EMBO J | 1994 | https://conductscience.org/library/papers/7925305 | PubMed |
| 7640209 | Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7640209 | PubMed |
| 7596980 | Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects. | Pharm Res | 1995 | https://conductscience.org/library/papers/7596980 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8095909
GET https://conductscience.org/api/papers/v1/8095909/authors